UK stocks traded strongly higher at midday Tuesday on rising optimism following government efforts to re-open economies, while disappointing corporate results from bellwethers BP and...
Barclays Capital today reaffirms its equal weight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 2200p (from 1950p).